Wound infections involving infrainguinal autogenous vein grafts: a current evaluation of factors determining successful graft preservation

Journal of Vascular Surgery
G S TreimanR L Treiman

Abstract

The purpose of this study was to review the natural history and clinical outcome of patients with infrainguinal autogenous graft infection (IAGI), to evaluate the effectiveness of attempted graft preservation, to determine those variables associated with graft salvage, and to better determine optimal treatment. We retrospectively reviewed the records of patients undergoing infrageniculate vein grafts at three hospitals between 1994 and 2000 who had a wound infection involving the graft. Clinical and bacteriologic variables were analyzed and correlated with graft salvage, limb salvage, and clinical outcome. During this 7-year period, 487 patients underwent an infrageniculate vein graft, and 68 (13%) had clinical evidence of IAGI. Twenty-seven patients presented with drainage from the wound, 15 with wound separation and cellulitis, 18 with soft tissue infection extending to the graft, 4 with an abscess and cellulitis, and 4 with bleeding. Ten patients (15%) had systemic symptoms (defined as a white blood cell count > 15,000 and temperature > 38.5 degrees C). Forty infections developed in the thigh, 17 in the groin, and 11 in the lower leg. An anastomosis was exposed in 15 patients. Wound cultures were positive for bacteria in 52 ...Continue Reading

References

Sep 1, 1992·American Journal of Surgery·K D CalligaroD A DeLaurentis
Apr 1, 1987·Journal of Vascular Surgery·M J KiktaD P Flanigan
Dec 1, 1995·Journal of Vascular Surgery·K D CalligaroD A DeLaurentis
Oct 6, 1997·Journal of Vascular Surgery·R B RutherfordD N Jones

❮ Previous
Next ❯

Citations

Jan 9, 2010·International Journal of Molecular Sciences·Anna V PiterinaTim M McGloughlin
Nov 4, 2015·Journal of Vascular Surgery·Kyla M BennettCynthia K Shortell
Dec 27, 2011·Injury·M R Tatterton, S Homer-Vanniasinkam
Nov 9, 2005·Journal of Vascular Surgery·James H BlackRichard P Cambria
Nov 10, 2009·ANZ Journal of Surgery·Amjid A RiazMichael C Ormiston
Dec 16, 2004·Annals of Vascular Surgery·Karl A IlligRichard M Green
Jul 26, 2006·Annals of Vascular Surgery·Evan J RyerPeter L Faries
Apr 5, 2011·Journal of Vascular Surgery·David Yu GreenblattMatthew W Mell
Jul 5, 2003·Journal of Vascular Surgery·Mark R NehlerWilliam C Krupski
Mar 6, 2003·Journal of Vascular Surgery·Mark R NehlerLloyd M Taylor
Dec 31, 2005·Vascular and Endovascular Surgery·Lori L PoundsLois A Killewich
Jul 16, 2004·Plastic and Reconstructive Surgery·Steven L MoranJoseph M Serletti
Jun 4, 2019·Annals of the Royal College of Surgeons of England·G ZenunajV Gasbarro
Oct 2, 2003·Vascular Medicine·Mark R NehlerJudith G Regensteiner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.